Tech Company M&A Transactions

Molecular Medicine BioServices Acquisition

On 5/8/2007, Molecular Medicine BioServices was acquired by Sigma-Aldrich. No transaction price was announced.

Transaction Overview

Acquired By
Announced On
5/8/2007
Transaction Type
M&A
Amount
Unknown
M&A Terms
Financial terms were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1890 Rutherford Road 200
Carlsbad, CA 92008
USA
Email Address
Not Recorded
Overview
Molecular Medicine BioServices (MMB) is dedicated to providing a variety of development, manufacturing, and ancillary services for the viral vaccine and viral therapeutic marketplace. In this exciting new field of biotechnology, MMB has been able to take advantage of new technologies for scale-up and purification of mammalian cell culture-derived viral products.
Profile
Molecular Medicine BioServices LinkedIn Company Profile
Social Media
Molecular Medicine BioServices Company Twitter Account
Company News
Molecular Medicine BioServices News
Facebook
Molecular Medicine BioServices on Facebook
YouTube
Molecular Medicine BioServices on YouTube

Management Team

Title
Name
Email & Social
President
David Backer
  David Backer LinkedIn Profile  David Backer Twitter Account  David Backer News  David Backer on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/8/2007: Xelerated venture capital transaction
Next: 5/8/2007: DepotPoint venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary